Nikos Karamanos
Nikos Karamanos
Professor of Biochemistry, University of Patras, Department of Chemistry, Greece
Verified email at - Homepage
Cited by
Cited by
Extracellular matrix structure
AD Theocharis, SS Skandalis, C Gialeli, NK Karamanos
Advanced drug delivery reviews 97, 4-27, 2016
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
C Gialeli, AD Theocharis, NK Karamanos
The FEBS journal 278 (1), 16-27, 2011
Glycosaminoglycans: key players in cancer cell biology and treatment
N Afratis, C Gialeli, D Nikitovic, T Tsegenidis, E Karousou, AD Theocharis, ...
The FEBS journal 279 (7), 1177-1197, 2012
Hyaluronan–CD44 interactions as potential targets for cancer therapy
S Misra, P Heldin, VC Hascall, NK Karamanos, SS Skandalis, ...
The FEBS journal 278 (9), 1429-1443, 2011
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
AD Theocharis, SS Skandalis, GN Tzanakakis, NK Karamanos
The FEBS journal 277 (19), 3904-3923, 2010
A guide to the composition and functions of the extracellular matrix
NK Karamanos, AD Theocharis, Z Piperigkou, D Manou, A Passi, ...
The FEBS journal 288 (24), 6850-6912, 2021
The extracellular matrix as a multitasking player in disease
AD Theocharis, D Manou, NK Karamanos
The FEBS journal 286 (15), 2830-2869, 2019
Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer
AG Tavianatou, I Caon, M Franchi, Z Piperigkou, D Galesso, ...
The FEBS journal 286 (15), 2883-2908, 2019
Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics
NK Karamanos, Z Piperigkou, AD Theocharis, H Watanabe, M Franchi, ...
Chemical reviews 118 (18), 9152-9232, 2018
Derivatization of carbohydrates for chromatographic, electrophoretic and mass spectrometric structure analysis
FN Lamari, R Kuhn, NK Karamanos
Journal of Chromatography B 793 (1), 15-36, 2003
Syndecans–key regulators of cell signaling and biological functions
NA Afratis, D Nikitovic, HAB Multhaupt, AD Theocharis, JR Couchman, ...
The FEBS journal 284 (1), 27-41, 2017
Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans
SS Skandalis, N Afratis, G Smirlaki, D Nikitovic, AD Theocharis, ...
Matrix Biology 35, 182-193, 2014
Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases
NK Karamanos, AD Theocharis, T Neill, RV Iozzo
Matrix Biology 75, 1-11, 2019
Inhibition of breast cancer cell proliferation by style constituents of different Crocus species
DG Chryssanthi, FN Lamari, G Iatrou, A Pylara, NK Karamanos, ...
Anticancer research 27 (1A), 357-362, 2007
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
P Zarogoulidis, E Chatzaki, K Porpodis, K Domvri, W Hohenforst-Schmidt, ...
International journal of nanomedicine, 1551-1572, 2012
Proteoglycans remodeling in cancer: Underlying molecular mechanisms
AD Theocharis, NK Karamanos
Matrix Biology 75, 220-259, 2019
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
E Karousou, S Misra, S Ghatak, K Dobra, M Götte, D Vigetti, A Passi, ...
Matrix Biology 59, 3-22, 2017
Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease
C Malavaki, S Mizumoto, N Karamanos, K Sugahara
Connective tissue research 49 (3-4), 133-139, 2008
Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells
P Bouris, SS Skandalis, Z Piperigkou, N Afratis, K Karamanou, AJ Aletras, ...
Matrix Biology 43, 42-60, 2015
Lumican, a small leucine‐rich proteoglycan
D Nikitovic, P Katonis, A Tsatsakis, NK Karamanos, GN Tzanakakis
IUBMB life 60 (12), 818-823, 2008
The system can't perform the operation now. Try again later.
Articles 1–20